Stryker Biotech Announces Eleven Cents Per Share Year-End Cash Dividend, A 22% Increase

KALAMAZOO, Mich., Dec. 7 /PRNewswire-FirstCall/-- Stryker Corporation announced today that the Board of Directors has declared a year- end cash dividend of eleven cents per share, an increase of 22% over the nine cent dividend declared in December 2004. The dividend is payable January 31, 2006 to shareholders of record at the close of business on December 30, 2005.

Stryker Corporation is one of the world's leading medical device companies with the most broadly-based range of products in orthopaedics and a significant presence in other medical specialties. The Company's products include implants that are used in joint replacement, trauma, craniomaxillofacial and spine surgeries; orthobiologics; operating room and interventional pain products; surgical navigation, endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment. In addition, Stryker provides outpatient physical therapy services in the United States.

Stryker Corporation

CONTACT: Dean H. Bergy, Vice President and Chief Financial Officer ofStryker Corporation, +1-269-385-2600

MORE ON THIS TOPIC